Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
474.30    -1.70 (-0.36%)
Bid:
474.20
Ask:
474.40
Spread: 0.20 (0.042%)
Market Cap: £5.91b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Ongoing incident at Garden Grove facility

26 May 2026 07:09

RNS Number : 6821F
Melrose Industries PLC
26 May 2026
 

26 May 2026

 

MELROSE INDUSTRIES PLC

 

Ongoing incident at Garden Grove facility in California

 

On Thursday 21 May, a thermal issue was identified regarding a storage tank containing methyl methacrylate (MMA) at GKN Aerospace's (GKN) Garden Grove facility in the US. MMA is a chemical used in the manufacture of high-strength aerospace acrylic materials. Action was taken immediately by GKN employees and emergency services notified.

 

As conditions evolved through Friday 22 May, the Orange County Fire Authority (OCFA) made the precautionary decision to issue mandatory evacuation orders for portions of the surrounding community to protect public safety while response operations continued.

Since then, technical specialists, the emergency services and the relevant authorities have continued to work closely to resolve the situation, with a focus on ensuring the safety of the local community, employees and everyone else involved.

 

As a result of the positive progress that has been made over the last few days and the reduced risk, on 25 May, the OCFA announced that the mandatory evacuation area had been significantly reduced with immediate effect.

 

At 6pm local time on 25 May, the local authorities confirmed that no injuries, leaks or contamination have occurred. GKN is working closely with customers on operational recovery and supply plans.

 

The progress made over the last few days is testament to the continued skill and dedication of all the support teams and services involved.

 

Further announcements will be issued as appropriate.

 

 

Enquiries:

 

Investor Relations:

 

Mat Wootton

 

+44 (0) 7483 961 233

mat.wootton@melroseplc.net

 

Media:

Simon Sporborg, Tom Pigott / Brunswick:

+44 (0) 207 404 5959

melrose@brunswickgroup.com

 

 

 

 

 

About Garden Grove

 

The Garden Grove facility in California, operated by GKN Aerospace Transparency Systems, Inc., designs, manufactures and provides aftermarket support for advanced military and commercial transparencies employing around 500 people. For financial year 2025, sales generated by the site were £136 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKSKAEKKEEA
Date   Source Headline
24th Jun 20227:30 amRNSTransaction in Own Shares
23rd Jun 20227:30 amRNSTransaction in Own Shares
22nd Jun 20227:30 amRNSTransaction in Own Shares
21st Jun 20227:30 amRNSTransaction in Own Shares
20th Jun 20227:30 amRNSTransaction in Own Shares
17th Jun 20227:30 amRNSTransaction in Own Shares
16th Jun 20227:30 amRNSTransaction in Own Shares
15th Jun 20227:30 amRNSTransaction in Own Shares
14th Jun 20227:30 amRNSTransaction in Own Shares
13th Jun 20227:30 amRNSTransaction in Own Shares
10th Jun 20227:30 amRNSTransaction in Own Shares
9th Jun 20225:30 pmRNSSustainability Report
8th Jun 20227:00 amRNSShare Buyback Programme
7th Jun 20224:45 pmRNSCapital Markets Day
6th Jun 20227:00 amRNSDisposal
1st Jun 202211:30 amRNSDirector/PDMR Shareholding
5th May 20224:09 pmRNSResult of AGM
5th May 20227:00 amRNSTrading Statement
7th Apr 20224:16 pmRNSDirector/PDMR Shareholding
31st Mar 20224:30 pmRNSNotice of AGM
25th Mar 20224:01 pmRNSStandard annual confirmation of post-offer
24th Mar 20224:33 pmRNSTR-1: Standard notification of major holdings
7th Mar 202211:20 amRNSDirector/PDMR Shareholding
3rd Mar 20222:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20222:45 pmRNSTR-1: Standard notification of major holdings
31st Dec 20218:27 amRNSDirector/PDMR Shareholding
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20213:24 pmRNSTR-1: Standard notification of major holdings
2nd Nov 20217:30 amRNSDirector Declaration
1st Nov 20218:00 amEQSEdison Investment Research Limited: Melrose Industries (MRO): Initiation - A proven, high-value creation model
25th Oct 20213:05 pmRNSDirector/PDMR Shareholding
22nd Oct 20215:00 pmRNSDirector/PDMR Shareholding
21st Oct 20213:50 pmRNSTR-1:Standard form notification of major holdings
8th Oct 20213:00 pmRNSTR-1:Standard form notification of major holdings
5th Oct 20217:00 amRNSTrading Statement
1st Oct 20214:30 pmRNSTR-1: Notification of major holdings
20th Sep 20215:20 pmRNSTR-1 Notification of major interest in shares
2nd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSReturn of Capital and Total Voting Rights
18th Aug 20215:00 pmRNSReturn of Capital and Total Voting Rights
30th Jul 20212:05 pmGNWForm 8.3 - Nortonlifelock Inc
9th Jul 202110:54 amRNSResults of General Meeting
24th Jun 20213:44 pmRNSDirector/PDMR Shareholding
22nd Jun 20213:31 pmRNSPosting of Circular and Notice of General Meeting
22nd Jun 20217:00 amRNSAir Management Disposal and Return of Capital
28th May 20214:00 pmRNSDirector/PDMR Shareholding
19th May 20214:48 pmRNSCapital Markets Event
6th May 20211:45 pmRNSResults of GM and AGM
6th May 20217:00 amRNSTrading Statement AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.